Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 15Triple Negative Breast Neoplasms 5Ovarian Neoplasms 4Prostatic Neoplasms 3Melanoma 3Lymphoma 3Lung Neoplasms 3Endometrial Neoplasms 3Uterine Cervical Neoplasms 2Multiple Myeloma 2Locally Advanced (Inoperable) or Metastatic Breast Cancer 2Leukemia 2Hematologic Neoplasms 2Healthy Participants 2Disease Progression 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1Moderate Hepatic Impairment 1

Interventions

pembrolizumab 25Cisplatin 20Carboplatin 14Paclitaxel 11Radiotherapy 9Radiotherapy, Intensity-Modulated 8Docetaxel 8Cetuximab 8Nivolumab 6cemiplimab 5Radiation 5durvalumab 4atezolizumab 3Taxes 3Surveys and Questionnaires 3Fluorouracil 3Drug Therapy 3Cyclophosphamide 3Blood Specimen Collection 3toripalimab 2olaparib 2fludarabine 2avelumab 2alpha-2'-deoxythioguanosine 2aldesleukin 2Surgical Procedures, Operative 2Standard of Care 2Pemetrexed 2Magnetic Resonance Spectroscopy 2vistusertib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Squamous Cell × capivasertib × 1 year × Clear all
NCT02664935 2026-04-28

National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer

University of Birmingham

Phase 2 Completed
423 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡